Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Diagnos Inc V.ADK

Alternate Symbol(s):  DGNOF

Diagnos Inc. is a Canadian company, which is engaged in early detection of critical health problems based on its FLAIRE artificial intelligence (AI) platform. FLAIRE allows for quick modifying and developing of applications, such as computer assisted retina analysis (CARA). CARA’s image enhancement algorithms provide sharper, clearer and easier-to-analyze retinal images. CARA is a tool for real-time screening of large volumes of patients. It provides software-based services to assist health specialists in the detection of diabetic retinopathy and other eye-related pathologies. Its geographical areas include Canada, the United States of America, Mexico, and Chile. The Company’s subsidiaries include Diagnos Internacional SA de CV and Diagnos Healthcare (India) Private Limited.


TSXV:ADK - Post by User

Bullboard Posts
Comment by LannyMcdonaldon Apr 16, 2018 1:46am
137 Views
Post# 27889085

RE:update on Saudi Arabia

RE:update on Saudi ArabiaHey Stef, its nice to see Yves-Stephane follow through on what was said in the last press release on the KSA..............This announcement by Kanhoor is very strategic for the growth of DIAGNOS in Saudi Arabia, the Gulf region and the Middle-East. We now have a highly technical savvy partner with strong ties in the market to sell our technology in this region of 22 countries. By creating a grading center in Saudi Arabia, we will strengthen our collaboration with this medical community and tremendously increase the efficiency of the screening process to benefit the patients. said Yves-Stphane Couture, DIAGNOS Vice-President of sales............."Excellent trip, great meetings and fantastic collaboration with health authority and hospitals".....................like the CEO said "Everything is going according to plan".........not as fast as investors would like........but.....like you said Stef "we will be screening millions" and I totally agree. Rashid Al Mugait, president of Kanhoor seems to be on a mission? Once he gets the ball rolling, look out, this will spread like wildfire!!!...Al Kanhoor is focusing on telemedicine in KSA providing technology for remote patients observation, marketing Diagnos suite of products in KSA and beyond....Wind Rashid up and turn him loose!!
Bullboard Posts